About Blue Rock Therapeutics
Blue Rock Therapeutics is a company based in Boston (United States) founded in 2016 was acquired by Leaps by Bayer in August 2019.. Blue Rock Therapeutics has raised $225 million across 1 funding round from investors including Versant Ventures and Leaps by Bayer. The company has 138 employees as of December 31, 2022. Blue Rock Therapeutics offers products and services including bemdaneprocel and OpCT-001. Blue Rock Therapeutics operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Boston, United States
- Employees 138 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bluerock Therapeutics Lp
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$225 M (USD)
in 1 rounds
-
Latest Funding Round
$225 M (USD), Series A
Dec 12, 2016
-
Investors
Versant Ventures
& 1 more
-
Employee Count
138
as on Dec 31, 2022
-
Acquired by
Leaps by Bayer
(Aug 08, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blue Rock Therapeutics
Blue Rock Therapeutics offers a comprehensive portfolio of products and services, including bemdaneprocel and OpCT-001. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational therapy for treating Parkinson's disease in clinical trials.
Therapy for primary photoreceptor diseases through iPSC-derived cells.
Unlock access to complete
Unlock access to complete
Leadership Team
46 people
Software Development Team
43 people
Product Management Team
29 people
Senior Team
25 people
Scientist Team
9 people
Principal Team
9 people
Human Resources and Administration
7 people
Legal and Compliance
6 people
Unlock access to complete
Funding Insights of Blue Rock Therapeutics
Blue Rock Therapeutics has successfully raised a total of $225M through 1 strategic funding round. The most recent funding activity was a Series A round of $225 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $225.0M
-
First Round
First Round
(12 Dec 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Series A - Blue Rock Therapeutics | Valuation | Versant Ventures , Leaps by Bayer |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Blue Rock Therapeutics
Blue Rock Therapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Versant Ventures and Leaps by Bayer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Blue Rock Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Blue Rock Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Blue Rock Therapeutics Comparisons
Competitors of Blue Rock Therapeutics
Blue Rock Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Blue Rock Therapeutics
Frequently Asked Questions about Blue Rock Therapeutics
When was Blue Rock Therapeutics founded?
Blue Rock Therapeutics was founded in 2016.
Where is Blue Rock Therapeutics located?
Blue Rock Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Blue Rock Therapeutics a funded company?
Blue Rock Therapeutics is a funded company, having raised a total of $225M across 1 funding round to date. The company's 1st funding round was a Series A of $225M, raised on Dec 12, 2016.
How many employees does Blue Rock Therapeutics have?
As of Dec 31, 2022, the latest employee count at Blue Rock Therapeutics is 138.
What does Blue Rock Therapeutics do?
Blue Rock Therapeutics was founded in 2016 and is based in Boston, United States. Operations center on the biotechnology sector, where stem cell therapeutics are developed to address cardiovascular and neurological conditions. The lead program targets heart muscle regeneration for patients recovering from heart attacks or managing chronic heart failure. Additional efforts extend to broader neurological applications through stem cell-based treatments.
Who are the top competitors of Blue Rock Therapeutics?
Blue Rock Therapeutics's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Blue Rock Therapeutics offer?
Blue Rock Therapeutics offers bemdaneprocel and OpCT-001.
Who are Blue Rock Therapeutics's investors?
Blue Rock Therapeutics has 2 investors. Key investors include Versant Ventures, and Leaps by Bayer.